Literature DB >> 13637583

The physical properties of chlorpropamide and its determination in human serum.

T J TOOLAN, R L WAGNER.   

Abstract

Entities:  

Keywords:  ANTIDIABETICS

Mesh:

Substances:

Year:  1959        PMID: 13637583     DOI: 10.1111/j.1749-6632.1959.tb39568.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  Chlorpropamide-induced leucine hypoglycemia.

Authors:  C LUCAS; G REAVEN
Journal:  J Clin Invest       Date:  1963-02       Impact factor: 14.808

2.  The bioavailability in man of marketed brands of chlorpropamide.

Authors:  A M Monro; P G Welling
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

3.  Neonatal hypoglycaemia in infants of diabetic mothers given sulphonylurea drugs in pregnancy.

Authors:  M L Kemball; C McIver; R D Milner; C H Nourse; D Schiff; J R Tiernan
Journal:  Arch Dis Child       Date:  1970-10       Impact factor: 3.791

Review 4.  Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.

Authors:  L Balant
Journal:  Clin Pharmacokinet       Date:  1981 May-Jun       Impact factor: 6.447

5.  A comparison of the effects of tolazamide and tolbutamide upon blood glucose and serum insulin and lipid levels in diabetic subjects.

Authors:  J A Moorhouse
Journal:  Can Med Assoc J       Date:  1967-03-04       Impact factor: 8.262

6.  A COMPARATIVE STUDY OF SOME BRANDS OF TOLBUTAMIDE AVAILABLE IN CANADA. I. CLINICAL ASPECTS.

Authors:  J B MCKENDRY; F C LU; D BICKERTON; G HANCHARYK
Journal:  Can Med Assoc J       Date:  1965-05-22       Impact factor: 8.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.